Follow-up of Patients Treated with Oral Doxycycline for Lyme neuroborreliosis
- 1 January 2001
- journal article
- research article
- Published by Taylor & Francis in Scandinavian Journal of Infectious Diseases
- Vol. 33 (4) , 259-262
- https://doi.org/10.1080/003655401300077225
Abstract
The clinical outcome for 69 patients treated with oral doxycycline for Lyme neuroborreliosis was studied retrospectively. The clinical follow-up time was 14 d to 2 y (median 7 months). All patients improved during and after treatment. A complete recovery was seen in 56 patients by 14 d to 9 months (median 6 weeks) after therapy, while 13 patients (19%) still had persistent sequelae 1 y after antibiotic treatment. Six patients were retreated because of new or persistent symptoms, but in no patient was a treatment failure proven. A questionnaire was sent to each patient, asking for time to recovery, sequelae and relapse of symptoms. No patient had experienced relapse of symptoms associated with Lyme neuroborreliosis when answering the questionnaire 2?9 y after treatment. Oral doxycycline seems to be an effective, convenient and inexpensive alternative for the treatment of Lyme neuroborreliosis.Keywords
This publication has 24 references indexed in Scilit:
- Successful Oral Doxycycline Treatment of Lyme Disease‐Associated Facial Palsy and MeningitisClinical Infectious Diseases, 1999
- In vitro-Empfindlichkeit von 30Borrelia-Stämmen gegenüber acht AntibiotikaInfection, 1996
- Therapeutic aspects of Lyme borreliosisClinics in Dermatology, 1993
- Borrelia burgdorferi ‐specific intrathecal antibody production in neuroborreliosisNeurology, 1993
- THE CLINICAL AND EPIDEMIOLOGICAL PROFILE OF LYME NEUROBORRELIOSIS IN DENMARK 1985–1990Brain, 1992
- Lyme neuroborreliosis: A new sensitive diagnostic assay for intrathecal synthesis of borrelia burgdorferi–specific immunoglobulin G, A, and MAnnals of Neurology, 1991
- Lyme DiseaseNew England Journal of Medicine, 1989
- Chronic Neurologic Manifestations of Erythema Migrans BorreliosisAnnals of the New York Academy of Sciences, 1988
- In vitro and in vivo susceptibility ofBorrelia burgdorferiEuropean Journal of Clinical Microbiology & Infectious Diseases, 1987
- CHRONIC MENINGITIS CAUSED BY A PENICILLIN-SENSITIVE MICROORGANISM?The Lancet, 1983